Latest News

Some of the news articles below may show only part of the news story. To view the full story, click on Read More below the story. 

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
  • January 26, 2023 3:53 PM | Becca Liebers (Administrator)

    APAOG is excited to release the Maternal Health Workforce Policy. Please click here to view. Contact our office with any questions. 

  • January 24, 2023 12:28 PM | Becca Liebers (Administrator)

    January Is Cervical Cancer Awareness Month
    ACOG Immunization Newsletter

    Please take some time this month to consider how you can take steps to educate your patients about gynecologic cancers, spread awareness among your patients and colleagues, and help reduce the risk of gynecologic cancers.

    On January 21, 2021, ACOG, alongside organizations representing a full range of practice areas that care for patients across the life span, released a joint statement on the elimination of HPV urging health care professionals to strongly recommend HPV vaccination to eligible patients and stress the benefits and safety of the HPV vaccine. According to Journal of the National Cancer Institute research, more than 35,000 cases of HPV-associated cancers are recorded in the United States each year—and the majority of them can be prevented. About 91% of cervical cancers are caused by HPV infection, further highlighting the critical importance of HPV screening and vaccination.

    The Advisory Committee on Immunization Practices and ACOG recommend routine HPV vaccination for children at the target age of 11–12 years as part of the adolescent immunization platform to reduce the incidence of anogenital cancer and genital warts associated with HPV infection. For some women ages 27–45 who are previously unvaccinated, obstetrician–gynecologists and other health care professionals may use shared clinical decision making regarding HPV vaccination, considering the patient’s risk for acquisition of a new HPV infection and whether the HPV vaccine may be beneficial.

    Resources for Clinicians:

    Resources for Patients:

  • January 23, 2023 9:19 AM | Becca Liebers (Administrator)

    APAOG, along with our newest partner, Alliance for Innovation on Maternal Health (AIM), is observing Maternal Health Awareness Day. This is a national effort established by American College of Obstetricians and Gynecologists (ACOG) to highlight the urgent maternal morbidity and mortality crisis in the U.S.

    Both AIM and ACOG are sharing lots of resources and information on their social media accounts. We have shared these to help spread the word and hope you will check them out!


  • January 17, 2023 8:38 AM | Becca Liebers (Administrator)

    Clinician Perspectives for Better IDD Care
    Hosted by: ABC3: Action to Build Clinical Confidence and Culture

    What is it?

    • Focus group discussions hosted by the ABC3 team on how to best motivate and prepare clinicians to serve people with IDD.

    Who is invited?

    • General clinicians with background experience as physicians, nurse practitioners, dentists, and physician associates.
    • We welcome all communication preferences.

    How can I be involved?

    • Attend a 90-minute focus group over Zoom in February.
    • There will be three sets of focus groups:
      • Clinicians with IDD: February 8
      • Generalists with no formal training to serve people with IDD: February 13
      • Clinicians of color: February 21
    • Meetings will be held at 5pm and 8pm EST.

    For more information, click here!

  • January 11, 2023 2:45 PM | Becca Liebers (Administrator)

    Who needs a fetal echocardiogram?

    Contemporary OB/GYN Journal, Vol 68 No 01, Volume 68, Issue 01 / Yalda Afshar, MD, PhDMark Sklansky, MD

    Congenital heart disease (CHD) is the most common major birth defect and represents the leading cause of infant death from a congenital anomaly.1,2 In high-resource settings, CHD accounts for roughly 4% of all neonatal deaths and 30% to 50% of deaths related to congenital anomalies.1,2 The incidence of CHD among live births is 6 to 12 per 1000 and is likely an underestimate given both spontaneous and elective terminations with CHD.3,4 Identified risk factors for fetal CHD are broadly placed into 3 categories: maternal factors, fetal factors, and familial risk factors. Considering these risk factors, patients with increased risk should be considered for fetal echocardiography.5 Here, we review the tenets of fetal echocardiography, including the risks, benefits, and the indications for appropriate referral (Figure 1).

    Read more.

  • January 10, 2023 8:54 AM | Becca Liebers (Administrator)

    The United States Congress designated January as Cervical Health Awareness Month. More than 14,000 women in the United States are diagnosed with invasive cervical cancer each year, but the disease is preventable with vaccination and appropriate screening.

    During January, NCCC and its many local chapters across the country highlight issues related to cervical cancer, HPV disease and the importance of early detection. While NCCC chapters host events throughout the year, January is a month with a special focus as chapters celebrate Cervical Health Awareness Month and work to spread the word in their communities.

    NCCC and the American Sexual Health Association (ASHA) also offer a range of resources (listed below) to educate the public and healthcare providers about cervical health, from fact sheets to episodes of ASHA’s Sex+Health podcast.

    For more information and resources, visit:

  • January 09, 2023 10:57 AM | Becca Liebers (Administrator)

    Presentations are now being accepted for the 2023 APAOG Annual Conference (July 17-19, 2023 in Milwaukee, WI). Presenters are asked to submit presentations to be considered. Presentations will be accepted until further notice. We estimate that all applicants will be notified of the status of their applications within two weeks of submission.

    Submit Here

  • January 06, 2023 9:44 AM | Becca Liebers (Administrator)

    #AIMUpdate  New Partnership!

    AIM’s mission is to support best practices that make birth safer, improve maternal health outcomes, and save lives. One of the ways we do this is through aligned partnerships with other organizations who work in maternal health and health equity.

    Our goals with partnering together are to include Physician Associates in the multidisciplinary development and implementation of AIM resources and share quality improvement tools and resources with its members.

    To learn more about AIM and its partners, please

    #AIMPartner #AIMForChange2023 #ACOG2023 #MaternalHealth #MaternalHealthMatters #MaternalHealthEquity

  • January 06, 2023 7:47 AM | Becca Liebers (Administrator)

    APAOG has leaders involved with the Enduring Guidelines Committee. With this, the new American Cancer Society National Roundtable on Cervical Cancer would very appreciate your and your organization’s help with identifying the initial priorities of the Roundtable.

    Below are links to a 10-minute survey that you may use and share with others, including through organization newsletters.

    They hope to hear from persons with the lived experience of either never being screened for cervical cancer, having a positive cervical cancer screening that has required follow-up, or having been diagnosed with cervical cancer or cervical pre-cancer that required treatment, particularly those from historically underrepresented populations and people experiencing health disparities. We encourage you to help us reach these communities with the survey link for patients. The partner link is for organizations and health systems. (The survey questions are the same for all 3 links; only the demographics questions differ.)

  • January 05, 2023 9:10 AM | Becca Liebers (Administrator)

    Abortion Is Essential Health Care
    FDA Finalizes Updated REMS for Mifepristone

    Yesterday, the FDA finalized the updated risk evaluation and mitigation strategy (REMS) for mifepristone for reproductive health indications, permanently removing the in-person dispensing requirement against which ACOG has long advocated and, for the first time, allowing brick-and-mortar pharmacies to join mail-order pharmacies in dispensing mifepristone.

    In a statement, ACOG President Iffath Abbasi Hoskins, MD, FACOG, said, “Since 2020, continued usage of mifepristone for abortion care without the in-person dispensing requirement has been shown to be safe and effective, and the official change to the REMS means that clinicians now have concrete peace of mind that this regulation which has proven to be unnecessary has been removed.” Read the full statement.

    ACOG will update all relevant guidance documents and resources about mifepristone for reproductive health indications.

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
Powered by Wild Apricot Membership Software